Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Dual function of ERH in primary miRNA biogenesis.

Nucleic acids research·2026
Same author

Bacterial infection reshapes monocyte and macrophage ontogeny at the CNS borders.

Science immunology·2026
Same author

Necroptosis triggers inflammatory interferon signatures in patient-derived metastatic breast cancer organoids.

Signal transduction and targeted therapy·2026
Same author

FAS-controlled T cells drive lymphoproliferation through glycolysis without effector differentiation.

Journal of human immunity·2026
Same author

WORK-RELATED MUSCULOSKELETAL SYMPTOMS AMONG SONOGRAPHY PRACTITIONERS IN THE UAE: A CROSS-SECTIONAL STUDY.

Georgian medical news·2026
Same author

Comparative insights into the apoptosome, inflammasomes and PIDDosome.

Nature reviews. Immunology·2026

Video Experimental Relacionado

Updated: Jun 23, 2026

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover
08:03

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover

Published on: May 23, 2016

10.8K

El PIDDosome controla la poliploidía de los cardiomiocitos durante el desarrollo posnatal del corazón

M Leone1, N Kinz2, F Eichin2

  • 1Biocenter, Institute for Developmental Immunology, Medical University of Innsbruck, Innsbruck, Austria. macileo@hotmail.com.

Cell death and differentiation
|January 12, 2026
PubMed
Resumen

El complejo PIDDosome restringe la poliploidía en las células cardíacas durante el desarrollo. La pérdida de la función del PIDDosome aumenta la ploidía celular, lo que podría afectar la función cardíaca en ratones de edad avanzada.

Palabras clave:
PIDDosomecardiomiocitospoliploidíadesarrollo cardíacofunción cardíacaregeneración cardíaca

Más Videos Relacionados

Isolation, Culture and Transduction of Adult Mouse Cardiomyocytes
08:42

Isolation, Culture and Transduction of Adult Mouse Cardiomyocytes

Published on: August 28, 2016

28.2K
Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis
08:41

Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis

Published on: October 7, 2020

7.6K

Videos de Experimentos Relacionados

Last Updated: Jun 23, 2026

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover
08:03

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover

Published on: May 23, 2016

10.8K
Isolation, Culture and Transduction of Adult Mouse Cardiomyocytes
08:42

Isolation, Culture and Transduction of Adult Mouse Cardiomyocytes

Published on: August 28, 2016

28.2K
Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis
08:41

Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis

Published on: October 7, 2020

7.6K

Área de la Ciencia:

  • Cardiología
  • Biología Celular
  • Biología del Desarrollo

Sus antecedentes:

  • Los cardiomiocitos (CM) de mamíferos adultos son postmitóticos y poliploides.
  • Comprender la salida del ciclo celular de los CM y la poliploidía es crucial para las terapias de regeneración cardíaca.

Objetivo del estudio:

  • Investigar el papel del complejo PIDDosome en la regulación de la poliploidía de los cardiomiocitos (CM) durante el desarrollo posnatal del corazón.
  • Determinar el impacto del control de la poliploidía mediado por el PIDDosome en la estructura y función cardíaca.

Principales métodos:

  • Análisis del contenido de ADN para evaluar la ploidía de los cardiomiocitos.
  • Investigación de los mecanismos de activación del PIDDosome que involucran ANKRD26 y PIDD1.
  • Utilización de secuenciación de ARN nuclear y experimentos de deleción genética.
  • Evaluación de la estructura y función cardíaca en ratones con actividad alterada del PIDDosome.

Principales resultados:

  • La pérdida de PIDDosome a nivel de célula es autónoma y conduce a un aumento de la ploidía nuclear y celular de los CM.
  • El control de la poliploidía impuesto por el PIDDosome ocurre entre el día postnatal 7 y P14.
  • La activación del PIDDosome requiere ANKRD26 y dirige PIDD1 a los centróolos madre.
  • El aumento de la ploidía debido a la pérdida de PIDDosome afecta la función cardíaca en ratones de edad avanzada.
  • El PIDDosome limita la poliploidización de los CM independientemente de p53, pero requiere la inducción de p21/Cdkn1a.

Conclusiones:

  • El complejo PIDDosome juega un papel clave en la implementación de un programa de diferenciación específico de CM que limita la poliploidía durante el desarrollo posnatal del corazón.
  • El control mediado por el PIDDosome de la poliploidía de los CM es esencial para mantener la función cardíaca, particularmente en la vejez.
  • Estos hallazgos ofrecen nuevas perspectivas sobre la restricción de la proliferación de CM poliploides y tienen implicaciones para las terapias regenerativas cardíacas.